Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
SENS Transcript
Senseonics Holdings, Inc. (SENS) Q1 2026 Earnings Call Transcript
Unknown5-8
The earnings call presents mixed signals: while there are positive aspects such as increased revenues, strong retention rates, and seamless transitions, these are counterbalanced by increased expenses, net losses, and vague guidance on partnerships. The Q&A section highlights concerns over partnership timelines and cost efficiencies. The lack of clear guidance and the increase in expenses and net loss weigh down the overall sentiment, leading to a neutral prediction for the stock price movement over the next two weeks.
Senseonics Holdings, Inc. (SENS) Q4 2025 Earnings Call Transcript
Positive3-2
The earnings call summary shows a positive sentiment with a 20% revenue increase and improved gross margins. Despite a net loss, it has narrowed significantly, indicating better cost management. The strategic plan outlines growth expectations and new product launches, which are promising. The lack of clear management responses in the Q&A is a concern but not enough to offset the positive financials and strategic outlook. Overall, the sentiment is positive, anticipating a stock price increase of 2% to 8%.
Senseonics Holdings, Inc. (SENS) Q3 2025 Earnings Call Transcript
Positive11-5
The earnings call highlights strong financial performance with improved gross margins and reduced net loss. The company is expanding its market presence with product launches in Europe and increased DTC marketing spend. Despite some uncertainties in timelines and payer transitions, the guidance is optimistic with expected patient growth and revenue. Positive trends in patient acquisition and competitive dynamics further support a positive outlook. The Q&A section indicates management's confidence in growth opportunities, although some details were vague. Overall, the sentiment is positive, likely leading to a stock price increase of 2% to 8%.
Senseonics Holdings, Inc. (SENS) Q2 2025 Earnings Call Transcript
Positive8-6
The earnings call shows strong financial performance with a 37% increase in net revenue and improved gross profit margins. Despite a net loss, the company reduced R&D expenses and increased cash position through public offerings. The Q&A section highlights positive retention rates and potential growth from the consignment program and Eon Care. However, there are uncertainties in retention data for the 365 version and revenue impact from Eon Care. Overall, the financial results and strategic initiatives suggest a positive stock price movement in the short term.
SENS Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
